Ads
related to: Bausch Lomb
Search results
Bausch + Lomb Corporation (BLCO) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. Bausch + Lomb Corporation (NYSE: BLCO)Q2 2022 Earnings CallAug 04,...
All You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy
Zacks via Yahoo Finance· 4 days agoBausch + Lomb (BLCO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about...
Bausch + Lomb (BLCO) Q1 Earnings Lag Estimates
Zacks via Yahoo Finance· 11 months agoBausch + Lomb (BLCO) delivered earnings and revenue surprises of -28.57% and 3.98%, respectively, for the quarter ended March 2023. Do the numbers hold...
Bausch + Lomb Corporation's (NYSE:BLCO) Stock is Soaring But Financials Seem Inconsistent: Will The...
Simply Wall St. via Yahoo Finance· 1 year agoBausch + Lomb's (NYSE:BLCO) stock is up by a considerable 12% over the past three months. But the...
Bausch + Lomb Corporation (NYSE:BLCO) Yearly Results: Here's What Analysts Are Forecasting For This...
Simply Wall St. via Yahoo Finance· 1 month agoShareholders will be ecstatic, with their stake up 23% over the past week following Bausch + Lomb...
Bausch + Lomb (BLCO) Expected to Beat Earnings Estimates: Should You Buy?
Zacks via Yahoo Finance· 1 month agoBausch + Lomb (BLCO) possesses the right combination of the two key ingredients for a likely...
Lacklustre Performance Is Driving Bausch + Lomb Corporation's (NYSE:BLCO) Low P/S
Simply Wall St. via Yahoo Finance· 11 months agoWith a price-to-sales (or "P/S") ratio of 1.5x Bausch + Lomb Corporation (NYSE:BLCO) may be sending...
Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink
Benzinga via Yahoo Finance· 9 months agoBausch + Lomb Corporation (NYSE: BLCO) has acquired Johnson & Johnson's (NYSE: JNJ) eye and contact...
Bausch + Lomb buys Novartis drugs for $1.75 billion to boost eye-care portfolio
Reuters via Yahoo Finance· 9 months agoThe deal includes acquisition of Novartis' anti-inflammation eye drop Xiidra, experimental drug...
Is Bausch + Lomb Corporation (NYSE:BLCO) Trading At A 39% Discount?
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Bausch + Lomb fair value estimate is...
Ad
related to: Bausch Lomb